New ST623 of Cryptococcus neoformans isolated from a patient with non-Hodgkin’s lymphoma in the Brazilian Amazon

BACKGROUND: Cryptococcosis is a disease of wide geographic distribution. It is most critical when it affects immunocompromised patients, with AIDS, tuberculosis or other diseases that require prolonged hospitalization. METHODS: This study described a case report, molecular epidemiology, the phylogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Lucyane Mendes, Ferreira, William Antunes, Filho, Roberto Alexandre Alves Barbosa, Lacerda, Marcus Vinícius Guimarães, Ferreira, Guilherme Motta Antunes, Saunier, Maria de Nazaré, Macedo, Marielle Machado, Cristo, Denise de Almeida, Alves, Marla Jalene, Jackisch-Matsuura, Ani Beatriz, Ferreira, Cristina Motta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238607/
https://www.ncbi.nlm.nih.gov/pubmed/32434527
http://dx.doi.org/10.1186/s12941-020-00361-3
Descripción
Sumario:BACKGROUND: Cryptococcosis is a disease of wide geographic distribution. It is most critical when it affects immunocompromised patients, with AIDS, tuberculosis or other diseases that require prolonged hospitalization. METHODS: This study described a case report, molecular epidemiology, the phylogenetic relationship, along with antifungal susceptibility test of a new ST 623 of C. neoformans isolated in a patient with non-Hodgkin’s Lymphoma, from Manaus, Brazil. RESULTS: The new C. neoformans was susceptible to all antifungal drugs tested. Our results showed that ST623 new clone has no evident evolutionary proximity to any other ST of the VNI subtype group identified in Brazil. CONCLUSIONS: In the context of phylogenetic analysis, this new genotype belongs to VNI subtype, and subsequencing complete genome studies are necessary to better understand the phylogenetic relationships amongst STs in this group.

Ejemplares similares